Researchers Use GM Soy to Produce Anti-HIV Protein

— Written By
en Español

El inglés es el idioma de control de esta página. En la medida en que haya algún conflicto entre la traducción al inglés y la traducción, el inglés prevalece.

Al hacer clic en el enlace de traducción se activa un servicio de traducción gratuito para convertir la página al español. Al igual que con cualquier traducción por Internet, la conversión no es sensible al contexto y puede que no traduzca el texto en su significado original. NC State Extension no garantiza la exactitud del texto traducido. Por favor, tenga en cuenta que algunas aplicaciones y/o servicios pueden no funcionar como se espera cuando se traducen.

English is the controlling language of this page. To the extent there is any conflict between the English text and the translation, English controls.

Clicking on the translation link activates a free translation service to convert the page to Spanish. As with any Internet translation, the conversion is not context-sensitive and may not translate the text to its original meaning. NC State Extension does not guarantee the accuracy of the translated text. Please note that some applications and/or services may not function as expected when translated.

Collapse ▲

Andreia Verdélio reports from Agência Brasil

Biotechnology is increasingly pointing out new directions for the pharmaceutical industry. The latest news is that researchers at Brazil’s Agricultural Research Corporation (EMBRAPA) have successfully extracted and purified cyanovirin-N grown in genetically modified soybeans. Cyanovirin-N is a protein found in cyanobacteria that can prevent HIV from proliferating in the human body.

The study published in Science magazine confirmed that GM soybean seeds are currently the most effective biofactory and a viable alternative for producing the protein in large scale. “We have been working to achieve this for five or six years. We have successfully accumulated a large amount of cyanovirin in soybeans and purified it,” said Elíbio Rech, a researcher at EMBRAPA Genetic Resources and Biotechnology.

Read more.